Catalyst Wire Dossier Catalyst Wire Dossier

ASA404

vadimezan · Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for ASA404, covering 2011-09-02 to 2020-12-24. Get the full timeline:

Most recent: Clinical Trial Update: ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer [Phase 3]

See pricing